Position in ELAN
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$442
+$12 QoQ
Shares Held
18
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#496
of 515 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Dunhill Financial, LLC holds $64,818 across 11 Drug Manufacturers - Specialty & Generic names. ELAN ranks #8 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
55 | $29,800 | |
| 2 | ZTS |
Zoetis Inc.
|
353 | $25,366 | |
| 3 | VTRS |
Viatris Inc
|
309 | $4,906 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
12 | $2,022 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
7 | $776 | |
| 6 | RDY |
Dr Reddys Laboratories Ltd
|
50 | $724 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
16 | $554 | |
| 8 | ELAN |
Elanco Animal Health Inc
This page
|
18 | $442 |
All Filings in ELAN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $442 | 18 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $430 | 18 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $226 | 10 | Shares | Sole | 2026-01-29 | |
| No filing history on record for this holder in this stock. | ||||||